Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

NCT01378377 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class

Stopped The trial was stopped due to the toxicities observed with the combination of pimasertib and temsirolimus.

Conditions

Interventions

Sponsor

EMD Serono